Company Neurokine Pharmaceuticals Inc Other OTC
Equities
CAC611561100
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
07-02 | BetterLife Pharma Inc. announced that it has received CAD 0.175 million in funding | CI |
06-27 | BetterLife Pharma Inc. Reports Earnings Results for the First Quarter Ended April 30, 2024 | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 07-09-16 |
Moira Ong
DFI | Director of Finance/CFO | 49 | 10-12-25 |
Chief Operating Officer | 67 | - | |
Wolfgang Renz
BRD | Director/Board Member | 54 | 15-02-04 |
David Melles
IRC | Investor Relations Contact | - | 21-09-28 |
Anthony Calandra
LAW | General Counsel | - | - |
Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 07-09-16 |
Robert Metcalfe
BRD | Director/Board Member | 84 | 20-01-20 |
Wolfgang Renz
BRD | Director/Board Member | 54 | 15-02-04 |
Ralph Pullen
BRD | Director/Board Member | 79 | 20-05-04 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 122,729,397 | 90,632,281 ( 73.85 %) | 0 | 73.85 % |
Company contact information
BetterLife Pharma, Inc.
1275 West 6th Avenue Suite 300
V6H 1A6, Vancouver
+
http://www.abetterlifepharma.com![address Neurokine Pharmaceuticals Inc](https://cdn.zonebourse.com/static/address/17068088.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+19.40% | 126B | |
+22.79% | 118B | |
+23.26% | 27.87B | |
-19.33% | 20.95B | |
-15.13% | 16.92B | |
-14.63% | 16.18B | |
+9.48% | 14.84B | |
-46.10% | 14.79B | |
+50.47% | 14.08B |
- Stock Market
- Equities
- BETRF Stock
- Stock
- Company Neurokine Pharmaceuticals Inc